Nutritional supplementation for older adults with hip fractures
Official title: Can Complex Carbohydrates and Essential Amino Acid Supplementation Improve Outcomes Following Geriatric Hip Fractures
Run by NYU Langone Health · NCT06773000 · Data updated 2026-11-12
This study tests whether a special nutritional supplement can help older adults with hip fractures keep their muscle strength during recovery compared to regular nutritional advice.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 65 Years and up |
| Sex | All |
| Enrollment | 118 (estimated) |
| Sponsor | NYU Langone Health Academic / other |
| Locations | 1 site (New York, New York) |
| Status | Recruiting |
| Started | January 16, 2025 |
| Main results expected | June 30, 2027 |
| Study ends | June 30, 2027 |
| Registry record updated | March 3, 2026 |
| Trial ID | NCT06773000 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are individuals aged 65 years or older who have sustained a geriatric hip fracture requiring surgical intervention.
✕Probably not a fit
Patients with pre-existing mobility impairments or severe organ dysfunction may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This clinical trial compares the outcomes of older adults with hip fractures who receive a specific nutritional supplement to those who receive standard nutritional counseling. Participants will be randomly assigned to either the supplement group or the control group and monitored for muscle loss through ultrasound measurements of the rectus femoris muscle in the uninjured leg. The study aims to determine if the nutritional supplement can effectively reduce muscle loss during the recovery period following surgery.
Why it matters
Potential benefit: If successful, this study could help improve recovery outcomes and reduce muscle loss in older adults after hip fractures.
How similar studies have gone: Other studies have shown promising results with nutritional supplementation in similar populations, suggesting potential for success in this approach.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: 1. Male or female, aged 65 years or older. 2. Presenting with a geriatric hip fracture (femoral neck, intertrochanteric, or subtrochanteric) requiring surgical intervention. 3. Able to provide informed consent. 4. Expected to survive at least 6 months after surgery, with no terminal illness. Exclusion Criteria: 1. Pre-existing conditions that significantly impair mobility prior to injury. 2. Severe renal or liver impairment. 3. Active treatment with investigational drugs or participation in another clinical trial within the last 30 days. 4. Inability to tolerate oral nutritional supplementation due to gastrointestinal disorders. 5. Allergies to any components of the nutritional supplement being tested.
Where it's running
-
NYU Langone Health
New York, New York, United States Recruiting
Study contacts
- Principal investigator: Abhishek Ganta, MD — NYU Langone Health
- Study coordinator: Abhishek Ganta, MD
- Email: Abhishek.ganta@nyulangone.org
- Phone: (951) 492-8945
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Medial unloader brace after root repair
This study tests whether using a medial unloader brace after arthroscopic medial meniscus posterior root repair helps healing and improves knee outcomes.
-
MAC-STILA: a feasibility test for hip fracture surgery anesthesia
This trial tests whether combining monitored anesthesia care with soft tissue infiltration using local anesthesia can reduce post-operative delirium in adults 65 and older undergoing hip fracture repair.
-
Osimertinib with Cyclosporine A for EGFR-mutant NSCLC
This phase II study tests whether adding cyclosporine A to osimertinib helps people with EGFR-mutant metastatic NSCLC who still have detectable tumor DNA in blood.
-
Histotripsy with chemotherapy and immunotherapy for biliary tract cancer
This pilot test will see if adding histotripsy to chemoimmunotherapy is safe and feasible for adults with biliary tract cancer.
-
A look at why Lewy body conditions cause visual hallucinations
This study tests brain‑imaging in people with Lewy body diseases who do or don’t experience visual hallucinations, and in healthy volunteers, to see how brain networks might create these images.
-
Virtual Reality Vision Testing for Metamorphopsia and Aniseikonia
A portable virtual reality headset is tested to see if it can more reliably and conveniently measure visual distortions in people with metamorphopsia or aniseikonia.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.